APC Anti-Mouse MHC II (I-A/I-E) Antibody[M5/114] (E-AB-F0990UE) elabscience
$190.00
In stock
SKU
E-AB-F0990UE
| Size | Price (USD) |
| 100μg | $190.00 |
| 25μg | $60.00 |
Product Details
| Abbre | MHC II |
| Synonyms | H2-Ab1/Eb1, I-E beta MHC class II, MHC class II, MHC class II H2-IA-beta-psi, Major histocompatibility protein class II beta chain |
| Swissprot | P14483 O78196 |
| Reactivity | Mouse |
| Host | Rat |
| Clonality | Monoclonal |
| Clone | M5/114 |
| Isotype | Rat IgG2b, κ |
| Isotype Control | APC Rat IgG2b, κ Isotype Control[LTF-2] |
| Applications | FCM |
| Conjugation | APC |
| Concentration | 0.2 mg/mL |
| Buffer | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer. |
| Research Areas | Immunology, Innate Immunity |
| Cellular Localization | Membrane |
Product Description
Conjugation Information: APC is designed to be excited by the Red (627-640 nm) laser and detected using an optical filter centered near 660 nm (e.g., a 660/20 nm bandpass filter).
Background: These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.
Storage and Shipping
| Storage | This product can be stored at 2-8°C for 24 months. Please protected from prolonged exposure to light and do not freeze. |
| Shipping | Ice bag |
- Targeted Inhibition of Tumor Extracellular Vesicle Secretion Improving the Anti-Tumor Immunity of Lymph Node-Targeted Vaccines
Journal: ADVANCED FUNCTIONAL MATERIALS | Year: 2025 | Impact Factor: 19.000
DOI: 10.1002/adfm.202504852 | Reactivity: Mouse | Sample Type: 3LL cell-Xenograft-draining lymph nodes (TDLNs) cell - Lacticaseibacillus rhamnosus MS27 Potentially Prevents Ulcerative Colitis Through Modulation of Gut Microbiota
Journal: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | Year: 2025 | Impact Factor: 4.900
DOI: 10.3390/ijms262311397 | Reactivity: Mouse | Sample Type: spleen lymphocyte - H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses
Journal: VIROLOGY | Year: 2025 | Impact Factor: 2.400
DOI: 10.1016/j.virol.2025.110672 | Reactivity: Mouse | Sample Type: splenocytes - Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
Journal: ACS Nano | Year: 2024 | Impact Factor: 15.800
DOI: 10.1021/acsnano.4c00392 | Reactivity: mouse - Structural characterization and adjuvant activity of a water soluble polysaccharide from Poria cocos
Journal: INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | Year: 2024 | Impact Factor: 7.700
DOI: 10.1016/j.ijbiomac.2024.133067 | Reactivity: Mouse | Sample Type: spleen lymphocyte - Single-dose of hybrid eukaryotic-prokaryotic nanovesicles to drive a rapid and controllable immune response against Klebsiella pneumoniae induced nosocomial pneumonia
Journal: Nano Today | Year: 2023 | Impact Factor: 17.400
DOI: 10.1016/j.nantod.2023.102135 | Reactivity: Mouse | Sample Type: broncho alveolar lavage fluid (BALF) - An Alternative Thinking in Tumor Therapeutics: Living Yeast Armored with Silicate
Journal: ACS Nano | Year: 2023 | Impact Factor: 17.100
DOI: 10.1021/acsnano.3c06311 | Reactivity: Mouse | Sample Type: dendritic cells (DCs) - The self-adjuvant heterocyclic lipid nanoparticles encapsulated with vaccine and STAT3 siRNA boost cancer immunotherapy through DLN-targeted and STING pathway
Journal: CHEMICAL ENGINEERING JOURNAL | Year: 2023 | Impact Factor: 15.100
DOI: 10.1016/j.cej.2023.146474 | Reactivity: Mouse | Sample Type: serum, Bone marrow-derived DCs (BMDCs) - Long-lasting postoperative analgesia with local anesthetic-loaded hydrogels prevent tumor recurrence via enhancing CD8+T cell infiltration
Journal: JOURNAL OF NANOBIOTECHNOLOGY | Year: 2023 | Impact Factor: 10.200
DOI: 10.1186/s12951-023-01803-8 | Reactivity: Mouse | Sample Type: spinal dorsal horn - In Vitro and In Vivo Dendritic Cell Immune Stimulation Effect of Low Molecular Weight Fucoidan from New Zealand Undaria pinnatifida
Journal: Marine Drugs | Year: 2022 | Impact Factor: 6.085
DOI: 10.3390/md20030197 | Reactivity: Mouse | Sample Type: Dendritic cells (DCs)
Reviews
Write Your Own Review